Some of the discussions were the following:
- Member States agreed to reduce the maximum residue levels (MRL) for pyraclostrobin in table grapes from 1 ppm to 0.3 ppm. The draft Regulation will be notified thought the World Trade Organization’ Sanitary and Phytosanitary Standards system (SPS-WTO).
- Although it was proposed the setting of an acute reference dose (ARfD) for fosetyl (in the context of the peer review for the renewal of approval of fosetyl), it was found that no ARfD should be set. The European Food Safety Authority (EFSA) will soon publish an amended conclusion on fosetyl.
- The Commission considered the EFSA Report on Processing Factors (PFs) a very useful source of information, but considered that its use in enforcement practice should not be legally binding or imposed on Member States. The use of default PFs should be left to the discretion of Member States. Most of the Members States do no use PFs or only use PFs to a limited extent to make decisions on non-compliances.
- The following Draft Commission Regulations had a favorable opinion:
- Draft Commission Regulation (EU) No …/… amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, captan, cyazofamid, flutianil, kresoxim-methyl, lambda-cyhalothrin, mandipropamid, pyraclostrobin, spiromesifen, spirotetramat, teflubenzuron and tetraconazole in or on certain products (Art. 10).
- Draft Commission Regulation (EU) No …/… amending Annexes II and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ABE-IT 56, aclonifen, Beauveria bassiana strain PPRI 5339, Clonostachys rosea strain J1446, fenpyrazamine, mefentrifluconazole and penconazole in or on certain products (Art. 10).
- Draft Commission Regulation (EU) No …/… amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bispyribac, denathonium benzoate, fenoxycarb, flurochloridone, quizalofop-P-ethyl, quizalofop-P-tefuryl, propaquizafop and tebufenozide (Art. 12).
- The Commission informed of the tentative planning for a vote on chlorate MRLs scheduled in Q2 or Q3 2019.
- As regards MRLs for imazalil, the Commission invited Member States to reflect on the possibility to set or maintain MRLs for commodities where no acute consumer risk was identified at or near the existing levels by March 31, 2019.
- There was an exchange of views as regards the MRLs for the following substances:
- Cyflufenamid, fenbuconazole, fluquinconazole, tembotrione, amitrole, fipronil, flufenoxuron, flupyrsulfuron-methyl, imazosulfuron, isoproturon, orthosulfamuron and triasulfuron in or on certain products.
- Cyflufenamid, fenbuconazole, fluquinconazole, tembotrione, amitrole, fipronil, flufenoxuron, flupyrsulfuron-methyl, imazosulfuron, isoproturon, orthosulfamuron and triasulfuron in or on certain products.
- The following Draft Commission Implementing Regulation had a favorable opinion:
- Draft Commission Implementing Regulation concerning the approval of the active substance Flutianil in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Draft Review Report SANTE/11948/2017 Rev 7).